SCHEMBL9192602

SCHEMBL9192602

OC(c1ccccc1)c1ccc2nccnc2c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.47
KDM5A P29375 1/20 0.42
ALDH1A1 P00352 1/20 0.41
MAPT P10636 1/20 0.41
LMNA P02545 1/20 0.41
KDM4E B2RXH2 1/20 0.41
OGA O60502 5/20 0.40
CHEK2 O96017 1/20 0.38
CA12 O43570 1/20 0.38
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38
CA9 Q16790 1/20 0.38
CA14 Q9ULX7 1/20 0.38
HPGD P15428 1/20 0.38
MET P08581 1/20 0.37
HDAC3 O15379 1/20 0.37
HDAC4 P56524 1/20 0.37
HDAC1 Q13547 1/20 0.37
HDAC7 Q8WUI4 1/20 0.37
HDAC8 Q9BY41 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9196171 0.89 CA12 (0.41) SMN1; SMN2KDM5AALDH1A1MAPTLMNA
SCHEMBL3418697 0.85 TGFBR1 (0.42) SMN1; SMN2KDM5ACHEK2
SCHEMBL7097024 0.81 ALDH1A1 (0.51) SMN1; SMN2KDM5AALDH1A1LMNAOGA
SCHEMBL8917474 0.81 MET (0.54) SMN1; SMN2ALDH1A1MAPTLMNAKDM4E
SCHEMBL17035971 0.77 MET (0.43) SMN1; SMN2KDM5AALDH1A1LMNAKDM4E
SCHEMBL29660594 0.76 SMN1; SMN2 (0.44) SMN1; SMN2ALDH1A1MAPTLMNACHEK2
SCHEMBL3275241 0.75 OGA (0.55) ALDH1A1MAPTKDM4EOGAHPGD
SCHEMBL30133836 0.75 OGA (0.55) ALDH1A1MAPTKDM4EOGAHPGD
SCHEMBL8671295 0.74 SMN1; SMN2 (0.58) SMN1; SMN2LMNAKDM4ECA12CA1
SCHEMBL13373326 0.73 SMN1; SMN2 (0.41) SMN1; SMN2ALDH1A1MAPTKDM4ECHEK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0371564-B1 (1H-azol-1-ylmethyl)substituted quinoline, quinazoline or quinoxaline derivatives JANSSEN PHARMACEUTICA NV (BE) 1995-07-12 EP disclosed
US-5151421-A Compounds for inhibition of metabolism of retinoids, for treatment for proliferation of epithelial cells and keratin disorders JANSSEN PHARMACEUTICA N.V. (BE) 1992-09-29 US disclosed
US-5028606-A Retinoid metabolism inhibitors JANSSEN PHARMACEUTICA N.V. (BE) 1991-07-02 US disclosed
EP-0371564-A2 (1H-azol-1-ylmethyl)substituted quinoline, quinazoline or quinoxaline derivatives JANSSEN PHARMACEUTICA N.V. (BE) 1990-06-06 EP disclosed